KSVCBD injection

BIOLOGICAL4 trials

Sponsors

Chinese PLA General Hospital

Conditions

Autoimmune DiseasesMultiple MyelomaNeuromyelitis Optica Spectrum Disease (NMOSD)Non-Hodgkin's Lymphoma

Early Phase 1

The Safety and Efficacy of KSVCBD Injection in Neuromyelitis Optica Spectrum Disorder.

Not yet recruitingNCT07592754

Chinese PLA General HospitalNeuromyelitis Optica Spectrum Disease (NMOSD)

Start: 2026-05-15End: 2029-03-31Target: 18Updated: 2026-05-18

Safety and Efficacy of KSVCBD Injection in Autoimmune Diseases

Not yet recruitingNCT07613411

Chinese PLA General HospitalAutoimmune Diseases

Start: 2026-06-01End: 2029-03-31Target: 60Updated: 2026-05-29

Phase 1

Safety and Efficacy of KSVCBD Injection in B-cell Non-Hodgkin's Lymphoma Expressing CD19 and/or BCMA

RecruitingNCT07620314

Chinese PLA General HospitalNon-Hodgkin's Lymphoma

Start: 2026-07-16End: 2029-03-30Target: 9Updated: 2026-07-20

Safety and Efficacy of KSVCBD Injection in Multiple Myeloma Expressing CD19 and/or BCMA

RecruitingNCT07620275

Chinese PLA General HospitalMultiple Myeloma

Start: 2026-09-03End: 2029-03-15Target: 9Updated: 2026-09-15